CDIO

Cardio Diagnostics Holdings, Inc.

Nasdaq · In Vitro & In Vivo Diagnostic Substances · Inc. DE · CIK 0001870144
$1.98 +2.06% $5.7M
Vol
Market Cap$5.7M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$65.7K
Inst. Activity1 buys / 0 sells
Exchange Nasdaq·Sector In Vitro & In Vivo Diagnostic Substances·Inc. DE·CIK 0001870144·Prev Close $1.94

Recent Activity

May 13, 2026 earnings_calendar
CDIO Q1 2026 Earnings Scheduled — 2026-05-13
Mar 31, 2026 Insider
Betts Wendy J sold 3,205 shares
Director @ $1.95 ($6.2K)
Mar 31, 2026 Insider
Burton Paul Frederick sold 3,205 shares
Director @ $1.95 ($6.2K)
Mar 31, 2026 Insider
Intrater James sold 3,205 shares
Director @ $1.95 ($6.2K)
Inst.
VANGUARD GROUP INC — ADD
24,124 shares ($97.2K)
Inst.
VANGUARD GROUP INC — NEW
12,682 shares ($45.7K)

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Aug 2024
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Aug 27, 2024 Benchmark REITERATE Speculative Buy → Speculative Buy
Jun 6, 2024 Benchmark MAINTAIN Speculative Buy → Speculative Buy
Apr 19, 2024 Benchmark MAINTAIN Speculative Buy → Speculative Buy
Jun 15, 2023 Benchmark REITERATE Speculative Buy → Speculative Buy
May 22, 2023 Northland Capital Markets INITIATE Outperform

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$65.4KADD
MORGAN STANLEY$271.00ADD
BANK OF AMERICA CORP$43.00

Recent Insider Trades

DateInsiderTypeValue
Mar 31, 2026Betts WendyA$6.2K
Mar 31, 2026Burton PaulA$6.2K
Mar 31, 2026Intrater JamesA$6.2K
Mar 31, 2026Fung PeterA$6.2K
3 institutional holders with $65.7K total value (24,240 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, BANK.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC24,124$65.4K99.5%ADD +90.2%
2MORGAN STANLEY100$271.000.4%ADD +50.0%
3BANK OF AMERICA CORP /DE/16$43.000.1%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
VANGUARD GROUP INCADD12,68224,124+90.2%$97.2K2025-Q3
VANGUARD GROUP INCNEW12,682$45.7K2025-Q2
VANGUARD GROUP INCEXIT372,5180-100.0%$0.002025-Q2
UBS Group AGEXIT167,1370-100.0%$0.002025-Q2
VANGUARD GROUP INCADD232,139372,518+60.5%$122.9K2025-Q1
UBS Group AGDOUBLED66,596167,137+151.0%$55.2K2025-Q1
MORGAN STANLEYADD3,0004,500+50.0%$1.5K2025-Q1
UBS Group AGNEW66,596$61.1K2024-Q4
MORGAN STANLEYDOUBLED1,0003,000+200.0%$2.8K2024-Q4
4 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Mar 31, 2026Betts Wendy JDirectorA3,205$1.95$6.2K
Mar 31, 2026Burton Paul FrederickDirectorA3,205$1.95$6.2K
Mar 31, 2026Intrater JamesDirectorA3,205$1.95$6.2K
Mar 31, 2026Fung Peter KDirectorA3,205$1.95$6.2K

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Aug 2024): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
2025-09-30
$0.00 $0.00 $0.00 $0.0B
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Aug 27, 2024 Benchmark REITERATE Speculative Buy Speculative Buy
Jun 6, 2024 Benchmark MAINTAIN Speculative Buy Speculative Buy
Apr 19, 2024 Benchmark MAINTAIN Speculative Buy Speculative Buy
Jun 15, 2023 Benchmark REITERATE Speculative Buy Speculative Buy
May 22, 2023 Northland Capital Markets INITIATE Outperform
Apr 18, 2023 Benchmark REITERATE Speculative Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Oct 1, 20252410086%
Aug 1, 20252410086%
Jul 1, 20252410086%
Jun 1, 20252410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 13, 2026
earnings_calendar
CDIO Q1 2026 Earnings Scheduled — 2026-05-13
Mar 18, 2026
earnings_calendar
CDIO Q4 2025 Earnings Scheduled — 2026-03-18
Mar 16, 2026
short_interest
FTD: CDIO — 181,533 shares ($0.5M) failed to deliver
Settlement: 20260316, Price: $2.80, FTD Value: $508,292.4, CARDIO DIAGNOSTICS HLDGS INC C
Mar 2, 2026
short_interest
FTD: CDIO — 117,864 shares ($0.8M) failed to deliver
Settlement: 20260302, Price: $6.55, FTD Value: $772,009.2, CARDIO DIAGNOSTICS HLDGS INC C
Feb 26, 2026
short_interest
FTD: CDIO — 96,100 shares ($0.5M) failed to deliver
Settlement: 20260226, Price: $5.31, FTD Value: $510,291, CARDIO DIAGNOSTICS HLDGS INC C
Feb 24, 2026
short_interest
FTD: CDIO — 359,903 shares ($1.1M) failed to deliver
Settlement: 20260224, Price: $3.01, FTD Value: $1,083,308.03, CARDIO DIAGNOSTICS HLDGS INC C
Feb 23, 2026
short_interest
FTD: CDIO — 492,837 shares ($1.4M) failed to deliver
Settlement: 20260223, Price: $2.88, FTD Value: $1,419,370.56, CARDIO DIAGNOSTICS HLDGS INC C
Feb 20, 2026
short_interest
FTD: CDIO — 239,947 shares ($0.5M) failed to deliver
Settlement: 20260220, Price: $2.24, FTD Value: $537,481.28, CARDIO DIAGNOSTICS HLDGS INC C